DB-1303

· DualityBio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DB-1303, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02) [Phase 3]

See pricing